Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (231-240 of 251) with videos related to

Pageof 26
Sort By:
Cancer|September 1, 1990
A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancerH E Windschitl, M J O'Connell, H S Wieand, et al.
Cancer|May 15, 1990
A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatinS Cullinan, C G Moertel, H S Wieand, et al.
JAMA|March 10, 1993
Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant testsD A Ahlquist, H S Wieand, C G Moertel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinomaT R Buroker, C G Moertel, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
The New England Journal of Medicine|March 14, 1991
Effective surgical adjuvant therapy for high-risk rectal carcinomaJ E Krook, C G Moertel, L L Gunderson, et al.
Journal of Surgical Oncology|October 1, 1986
Carcinoids: the prognostic effect of primary site histologic type variationsL A Johnson, P T Lavin, C G Moertel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinomaM A Poon, M J O'Connell, C G Moertel, et al.
The New England Journal of Medicine|February 8, 1990
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaC G Moertel, T R Fleming, J S Macdonald, et al.
Journal of Surgical Oncology|December 1, 1986
Gallbladder adenocarcinoma: prognostic significance of tumor acid mucopolysaccharide contentL A Johnson, P T Lavin, Y Y Dayal, et al.
Pageof 26

Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
Cancer|September 1, 1990
A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancerH E Windschitl, M J O'Connell, H S Wieand, et al.
Cancer|May 15, 1990
A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatinS Cullinan, C G Moertel, H S Wieand, et al.
JAMA|March 10, 1993
Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant testsD A Ahlquist, H S Wieand, C G Moertel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinomaT R Buroker, C G Moertel, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
The New England Journal of Medicine|March 14, 1991
Effective surgical adjuvant therapy for high-risk rectal carcinomaJ E Krook, C G Moertel, L L Gunderson, et al.
Journal of Surgical Oncology|October 1, 1986
Carcinoids: the prognostic effect of primary site histologic type variationsL A Johnson, P T Lavin, C G Moertel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinomaM A Poon, M J O'Connell, C G Moertel, et al.
The New England Journal of Medicine|February 8, 1990
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaC G Moertel, T R Fleming, J S Macdonald, et al.
Journal of Surgical Oncology|December 1, 1986
Gallbladder adenocarcinoma: prognostic significance of tumor acid mucopolysaccharide contentL A Johnson, P T Lavin, Y Y Dayal, et al.
Pageof 26